Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-12-12
2006-12-12
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
C514S167000
Reexamination Certificate
active
07148211
ABSTRACT:
The invention relates to pharmaceutical formulations of lipophilic therapeutic agents in which such agents are solubilized in largely aqueous vehicles, and processes for preparing and using the same.
REFERENCES:
patent: 2383446 (1945-06-01), Calcott et al.
patent: 3697559 (1972-10-01), DeLuca et al.
patent: 3741996 (1973-06-01), DeLuca et al.
patent: 3907843 (1975-09-01), DeLuca et al.
patent: 3932634 (1976-01-01), Kardys
patent: 4075333 (1978-02-01), Josse
patent: 4160803 (1979-07-01), Potts
patent: 4195027 (1980-03-01), DeLuca et al.
patent: 4202829 (1980-05-01), DeLuca et al.
patent: 4225596 (1980-09-01), DeLuca
patent: 4234495 (1980-11-01), DeLuca et al.
patent: 4260549 (1981-04-01), DeLuca et al.
patent: 4308264 (1981-12-01), Conway
patent: 4362710 (1982-12-01), Watanabe
patent: 4364941 (1982-12-01), Kiyoki et al.
patent: 4391802 (1983-07-01), Suda et al.
patent: 4508651 (1985-04-01), Baggiolini et al.
patent: 4554106 (1985-11-01), DeLuca et al.
patent: 4555364 (1985-11-01), DeLuca et al.
patent: 4588716 (1986-05-01), DeLuca et al.
patent: 4661294 (1987-04-01), Holick et al.
patent: 4689180 (1987-08-01), DeLuca et al.
patent: 4698328 (1987-10-01), Neer et al.
patent: 4717721 (1988-01-01), DeLuca et al.
patent: 4727064 (1988-02-01), Pitha
patent: 4784845 (1988-11-01), Desai
patent: 4816247 (1989-03-01), Desai
patent: 4833125 (1989-05-01), Neer et al.
patent: 4866048 (1989-09-01), Calverley et al.
patent: 4877778 (1989-10-01), Carpenter
patent: 4902481 (1990-02-01), Clark et al.
patent: 4948788 (1990-08-01), Makino
patent: 4948789 (1990-08-01), Slatopolsky
patent: 5063221 (1991-11-01), Nishii et al.
patent: 5085864 (1992-02-01), Cannon
patent: 5092840 (1992-03-01), Healy
patent: 5104864 (1992-04-01), DeLuca
patent: 5120720 (1992-06-01), Pitha
patent: 5124152 (1992-06-01), Biringer et al.
patent: 5134127 (1992-07-01), Stella
patent: 5141719 (1992-08-01), Fernwood et al.
patent: 5157135 (1992-10-01), Tsuji et al.
patent: 5158944 (1992-10-01), Makino
patent: 5182274 (1993-01-01), Makino
patent: 5205989 (1993-04-01), Aysta
patent: 5219528 (1993-06-01), Clark
patent: 5232836 (1993-08-01), Bouillon et al.
patent: 5260290 (1993-11-01), DeLuca et al.
patent: 5264184 (1993-11-01), Aysta et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5298246 (1994-03-01), Yano
patent: 5334740 (1994-08-01), Takahashi et al.
patent: 5338532 (1994-08-01), Tomalia et al.
patent: 5360413 (1994-11-01), Leason et al.
patent: 5366965 (1994-11-01), Strein
patent: 5372996 (1994-12-01), Labrie
patent: 5376645 (1994-12-01), Stella
patent: 5403831 (1995-04-01), DeLuca
patent: 5417923 (1995-05-01), Bojanic et al.
patent: 5474923 (1995-12-01), Takeda
patent: 5487900 (1996-01-01), Itoh
patent: 5488120 (1996-01-01), Knutson et al.
patent: 5527524 (1996-06-01), Tomalia et al.
patent: 5532229 (1996-07-01), Vieth
patent: 5549577 (1996-08-01), Siegel et al.
patent: 5554386 (1996-09-01), Groman et al.
patent: 5561123 (1996-10-01), DeLuca
patent: 5565442 (1996-10-01), Silver
patent: 5597575 (1997-01-01), Breitbarth
patent: 5602116 (1997-02-01), Knutson
patent: 5614513 (1997-03-01), Knutson et al.
patent: 5632315 (1997-05-01), Rose
patent: 5637742 (1997-06-01), Valles et al.
patent: 5645856 (1997-07-01), Lacy
patent: 5661025 (1997-08-01), Szoka, Jr. et al.
patent: 5668174 (1997-09-01), Kawagishi
patent: 5691328 (1997-11-01), Peterson et al.
patent: 5716346 (1998-02-01), Farris
patent: 5739271 (1998-04-01), Sridhar et al.
patent: 5763428 (1998-06-01), Knutson
patent: 5763429 (1998-06-01), Bishop
patent: 5766582 (1998-06-01), Yuen et al.
patent: 5795882 (1998-08-01), Bishop et al.
patent: 5798345 (1998-08-01), Knutson
patent: 5804573 (1998-09-01), Silver
patent: 5817648 (1998-10-01), Kutner
patent: 5827883 (1998-10-01), Barbier et al.
patent: 5858999 (1999-01-01), Su
patent: 5869386 (1999-02-01), Hamajima
patent: 5874418 (1999-02-01), Stella
patent: 5880114 (1999-03-01), DeLuca
patent: 5932544 (1999-08-01), Grinna
patent: 5939407 (1999-08-01), Landfield
patent: 5965160 (1999-10-01), Benita
patent: 5972917 (1999-10-01), Bishop
patent: 6045538 (2000-04-01), Farris
patent: 6046177 (2000-04-01), Stella
patent: 6051567 (2000-04-01), Abrahamson
patent: 6096338 (2000-08-01), Lacy
patent: 6136799 (2000-10-01), Li
patent: 6171603 (2001-01-01), Bernardon
patent: 6211169 (2001-04-01), Shinal
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6294192 (2001-09-01), Patel
patent: 6294548 (2001-09-01), James
patent: 6361758 (2002-03-01), Li
patent: 6406455 (2002-06-01), Willis et al.
patent: 6417177 (2002-07-01), Nelson
patent: 6436430 (2002-08-01), Mulye
patent: 6503893 (2003-01-01), Bishop et al.
patent: 6521608 (2003-02-01), Henner et al.
patent: 6537982 (2003-03-01), Bishop et al.
patent: 6538037 (2003-03-01), Bishop et al.
patent: 877 356 (1979-10-01), None
patent: 0197514 (1986-10-01), None
patent: 0390097 (1990-10-01), None
patent: 0503630 (1992-09-01), None
patent: 0562497 (1993-09-01), None
patent: 0664287 (1995-07-01), None
patent: 62000033 (1986-10-01), None
patent: 5320127 (1993-09-01), None
patent: 6025039 (1994-02-01), None
patent: WO 84/04527 (1984-11-01), None
patent: WO 87/00834 (1987-02-01), None
patent: WO 90/10620 (1990-09-01), None
patent: WO 92/05130 (1992-04-01), None
patent: WO 92/12165 (1992-07-01), None
patent: WO 92/21355 (1992-12-01), None
patent: WO 93/07883 (1993-04-01), None
patent: WO 93/14763 (1993-08-01), None
patent: WO 94/16711 (1994-08-01), None
patent: 96/36340 (1996-05-01), None
patent: WO 96/31215 (1996-10-01), None
patent: WO 96/40153 (1996-12-01), None
patent: WO 99/49870 (1999-10-01), None
patent: 00/61112 (2000-04-01), None
patent: WO 01/07075 (2001-02-01), None
patent: 02/15894 (2001-08-01), None
patent: WO 01/68017 (2001-09-01), None
patent: WO 02/34198 (2002-05-01), None
Aloia, J. et al.,Amer. J. Med., (1988) 84:401-08.
Barton, D. et al., “Synthetic Uses of Steroidal Ring & Diene Protection: 22,23-Dihydroergosterol,”JCS Perkin I, (1976) pp. 821-826.
Beer, et al., “A Phase I Trial of Pulse Calcitriol in Patients with Refractory Malignancies,”Cancer, (Jun. 15, 2001) 91:12:2431-2439.
Beer, et al., “Weekly High-Dose Calcitriol and Docetaxel in Advanced Prostate Cancer,”Seminars in Oncology, Suppl 15 (Aug. 2001) 28:4:49-55.
Beer, T. et al., “Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer,”Journal of Clinical Oncology, (Jan. 2003) 21:1:123-128.
Blazsek, I. et al. “Combined Differentiation Therapy in Myelodysplastic Syndrome with Retinoid Acid, 1α,25 Dihydroxyvitamin D3, and Prednisone,” 16:4:259-264 (Abstract).
Brautbar, N. “Osteoporosis: Is 1,25-(OH)2D3 of Value in Treatment?”Nephron(1986) 44:161-166.
Braunwald, E. et al.,Harrison's Principles of Internal Medicine: Part Eleven, “Disorders of Bone and Mineral Metabolism,” Chapter 335, McGraw-Hill, New York, (1987) pp. 1860-1865.
Brown, J.P. et al., “Serum Bone Gala-Protein: A Specific Marker for Bone Formation in Postmenopausal Osteoporosis,”Lancet, (1984) 1:1091-1093.
Caniggia, A. et al., “Effect of a Long-Term Treatment with 1,25-Dihydroxyvitamin D3on Osteocalcin in Postmenopausal Osteoporosis,”Cacified Tissue Int., (1986) 38:328-332.
Christiansen, C. et al., “Prevention of Early Postmenopausal Bone Loss: Controlled 2-Year Study in 315 Normal Females,”Europ J Clin Inves., (1980) 10:273-279.
Christiansen, C. et al.,Eur. J. Clin. Invest., (1981) 11:305-309.
Crump, D.R. et al., “(22S)-Hydroxyvitamin D4,”J.C.S. Perkins Trans. I, (1973) pp. 2731-2733.
Cho, Y.L. et al., “Combined Effects of 1,25-Dihydroxyvitamin D3and Platinum Drugs on the growth of MCF-7 Cells,”Cancer Research, (Jun. 1991) 51:2848-2853.
Defacque, H. et al., “Different Combinations of Retinoids and Vitamin D3Analogs Efficiently Promote Growth Inhibition and Differentiation of Myelomonocytic Leukemia Cell Lines,”J. Pharmacology and Experimental Therapeutics, (1994) 271:193-199.
DeLuca et al., “Synthesis, Biological Activity,
Driscoll Jeffrey W.
Goldensoph Creighton Reed
LeVan Leon W.
Mazess Richard B.
Genzyme Corporation
Michael & Best & Friedrich LLP
Mitchell G.
Padmanabhan Sreeni
Peterson Jeffrey D.
LandOfFree
Formulation for lipophilic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulation for lipophilic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for lipophilic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3712706